[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Coagulation Factor XI Market Report 2018

March 2018 | 102 pages | ID: U67B3DE02FCQEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Coagulation Factor XI market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Coagulation Factor XI in these regions, from 2013 to 2025 (forecast).
United States Coagulation Factor XI market competition by top manufacturers/players, with Coagulation Factor XI sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cambryn Biologics LLC
  • eXithera Pharmaceuticals, Inc
  • Ionis Pharmaceuticals, Inc.
  • LegoChem Biosciences, Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • MR-1007
  • IONIS-FXIRx
  • EP-7041
  • AB-022
  • BMS-262084
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Thrombosis
  • Bleeding and Clotting Disorders
  • Acute Ischemic Stroke
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Coagulation Factor XI Market Report 2018

1 COAGULATION FACTOR XI OVERVIEW

1.1 Product Overview and Scope of Coagulation Factor XI
1.2 Classification of Coagulation Factor XI by Product Category
  1.2.1 United States Coagulation Factor XI Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Coagulation Factor XI Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 MR-1007
  1.2.4 IONIS-FXIRx
  1.2.5 EP-7041
  1.2.6 AB-022
  1.2.7 BMS-262084
  1.2.8 Others
1.3 United States Coagulation Factor XI Market by Application/End Users
  1.3.1 United States Coagulation Factor XI Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Thrombosis
  1.3.3 Bleeding and Clotting Disorders
  1.3.4 Acute Ischemic Stroke
  1.3.5 Others
1.4 United States Coagulation Factor XI Market by Region
  1.4.1 United States Coagulation Factor XI Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Coagulation Factor XI Status and Prospect (2013-2025)
  1.4.3 Southwest Coagulation Factor XI Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Coagulation Factor XI Status and Prospect (2013-2025)
  1.4.5 New England Coagulation Factor XI Status and Prospect (2013-2025)
  1.4.6 The South Coagulation Factor XI Status and Prospect (2013-2025)
  1.4.7 The Midwest Coagulation Factor XI Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Coagulation Factor XI (2013-2025)
  1.5.1 United States Coagulation Factor XI Sales and Growth Rate (2013-2025)
  1.5.2 United States Coagulation Factor XI Revenue and Growth Rate (2013-2025)

2 UNITED STATES COAGULATION FACTOR XI MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Coagulation Factor XI Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Coagulation Factor XI Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Coagulation Factor XI Average Price by Players/Suppliers (2013-2018)
2.4 United States Coagulation Factor XI Market Competitive Situation and Trends
  2.4.1 United States Coagulation Factor XI Market Concentration Rate
  2.4.2 United States Coagulation Factor XI Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Coagulation Factor XI Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES COAGULATION FACTOR XI SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Coagulation Factor XI Sales and Market Share by Region (2013-2018)
3.2 United States Coagulation Factor XI Revenue and Market Share by Region (2013-2018)
3.3 United States Coagulation Factor XI Price by Region (2013-2018)

4 UNITED STATES COAGULATION FACTOR XI SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Coagulation Factor XI Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Coagulation Factor XI Revenue and Market Share by Type (2013-2018)
4.3 United States Coagulation Factor XI Price by Type (2013-2018)
4.4 United States Coagulation Factor XI Sales Growth Rate by Type (2013-2018)

5 UNITED STATES COAGULATION FACTOR XI SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Coagulation Factor XI Sales and Market Share by Application (2013-2018)
5.2 United States Coagulation Factor XI Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES COAGULATION FACTOR XI PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Coagulation Factor XI Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer AG Coagulation Factor XI Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 Coagulation Factor XI Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Cambryn Biologics LLC
  6.3.2 Coagulation Factor XI Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cambryn Biologics LLC Coagulation Factor XI Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 eXithera Pharmaceuticals, Inc
  6.4.2 Coagulation Factor XI Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Ionis Pharmaceuticals, Inc.
  6.5.2 Coagulation Factor XI Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 LegoChem Biosciences, Inc
  6.6.2 Coagulation Factor XI Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview

7 COAGULATION FACTOR XI MANUFACTURING COST ANALYSIS

7.1 Coagulation Factor XI Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Coagulation Factor XI

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Coagulation Factor XI Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Coagulation Factor XI Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES COAGULATION FACTOR XI MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Coagulation Factor XI Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Coagulation Factor XI Sales Volume Forecast by Type (2018-2025)
11.3 United States Coagulation Factor XI Sales Volume Forecast by Application (2018-2025)
11.4 United States Coagulation Factor XI Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Coagulation Factor XI
Figure United States Coagulation Factor XI Market Size (K Pcs) by Type (2013-2025)
Figure United States Coagulation Factor XI Sales Volume Market Share by Type (Product Category) in 2017
Figure MR-1007 Product Picture
Figure IONIS-FXIRx Product Picture
Figure EP-7041 Product Picture
Figure AB-022 Product Picture
Figure BMS-262084 Product Picture
Figure Others Product Picture
Figure United States Coagulation Factor XI Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Coagulation Factor XI by Application in 2017
Figure Thrombosis Examples
Table Key Downstream Customer in Thrombosis
Figure Bleeding and Clotting Disorders Examples
Table Key Downstream Customer in Bleeding and Clotting Disorders
Figure Acute Ischemic Stroke Examples
Table Key Downstream Customer in Acute Ischemic Stroke
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Coagulation Factor XI Market Size (Million USD) by Region (2013-2025)
Figure The West Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Coagulation Factor XI Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Coagulation Factor XI Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Coagulation Factor XI Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Coagulation Factor XI Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Coagulation Factor XI Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Coagulation Factor XI Sales Share by Players/Suppliers
Figure 2017 United States Coagulation Factor XI Sales Share by Players/Suppliers
Figure United States Coagulation Factor XI Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Coagulation Factor XI Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Coagulation Factor XI Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Coagulation Factor XI Revenue Share by Players/Suppliers
Figure 2017 United States Coagulation Factor XI Revenue Share by Players/Suppliers
Table United States Market Coagulation Factor XI Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Coagulation Factor XI Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Coagulation Factor XI Market Share of Top 3 Players/Suppliers
Figure United States Coagulation Factor XI Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Coagulation Factor XI Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Coagulation Factor XI Product Category
Table United States Coagulation Factor XI Sales (K Pcs) by Region (2013-2018)
Table United States Coagulation Factor XI Sales Share by Region (2013-2018)
Figure United States Coagulation Factor XI Sales Share by Region (2013-2018)
Figure United States Coagulation Factor XI Sales Market Share by Region in 2017
Table United States Coagulation Factor XI Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Coagulation Factor XI Revenue Share by Region (2013-2018)
Figure United States Coagulation Factor XI Revenue Market Share by Region (2013-2018)
Figure United States Coagulation Factor XI Revenue Market Share by Region in 2017
Table United States Coagulation Factor XI Price (USD/Pcs) by Region (2013-2018)
Table United States Coagulation Factor XI Sales (K Pcs) by Type (2013-2018)
Table United States Coagulation Factor XI Sales Share by Type (2013-2018)
Figure United States Coagulation Factor XI Sales Share by Type (2013-2018)
Figure United States Coagulation Factor XI Sales Market Share by Type in 2017
Table United States Coagulation Factor XI Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Coagulation Factor XI Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Coagulation Factor XI by Type (2013-2018)
Figure Revenue Market Share of Coagulation Factor XI by Type in 2017
Table United States Coagulation Factor XI Price (USD/Pcs) by Types (2013-2018)
Figure United States Coagulation Factor XI Sales Growth Rate by Type (2013-2018)
Table United States Coagulation Factor XI Sales (K Pcs) by Application (2013-2018)
Table United States Coagulation Factor XI Sales Market Share by Application (2013-2018)
Figure United States Coagulation Factor XI Sales Market Share by Application (2013-2018)
Figure United States Coagulation Factor XI Sales Market Share by Application in 2017
Table United States Coagulation Factor XI Sales Growth Rate by Application (2013-2018)
Figure United States Coagulation Factor XI Sales Growth Rate by Application (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Coagulation Factor XI Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer AG Coagulation Factor XI Sales Growth Rate (2013-2018)
Figure Bayer AG Coagulation Factor XI Sales Market Share in United States (2013-2018)
Figure Bayer AG Coagulation Factor XI Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Coagulation Factor XI Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Coagulation Factor XI Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Coagulation Factor XI Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Coagulation Factor XI Revenue Market Share in United States (2013-2018)
Table Cambryn Biologics LLC Basic Information List
Table Cambryn Biologics LLC Coagulation Factor XI Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cambryn Biologics LLC Coagulation Factor XI Sales Growth Rate (2013-2018)
Figure Cambryn Biologics LLC Coagulation Factor XI Sales Market Share in United States (2013-2018)
Figure Cambryn Biologics LLC Coagulation Factor XI Revenue Market Share in United States (2013-2018)
Table eXithera Pharmaceuticals, Inc Basic Information List
Table eXithera Pharmaceuticals, Inc Coagulation Factor XI Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure eXithera Pharmaceuticals, Inc Coagulation Factor XI Sales Growth Rate (2013-2018)
Figure eXithera Pharmaceuticals, Inc Coagulation Factor XI Sales Market Share in United States (2013-2018)
Figure eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue Market Share in United States (2013-2018)
Table Ionis Pharmaceuticals, Inc. Basic Information List
Table Ionis Pharmaceuticals, Inc. Coagulation Factor XI Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Coagulation Factor XI Sales Growth Rate (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Coagulation Factor XI Sales Market Share in United States (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue Market Share in United States (2013-2018)
Table LegoChem Biosciences, Inc Basic Information List
Table LegoChem Biosciences, Inc Coagulation Factor XI Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure LegoChem Biosciences, Inc Coagulation Factor XI Sales Growth Rate (2013-2018)
Figure LegoChem Biosciences, Inc Coagulation Factor XI Sales Market Share in United States (2013-2018)
Figure LegoChem Biosciences, Inc Coagulation Factor XI Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Coagulation Factor XI
Figure Manufacturing Process Analysis of Coagulation Factor XI
Figure Coagulation Factor XI Industrial Chain Analysis
Table Raw Materials Sources of Coagulation Factor XI Major Players/Suppliers in 2017
Table Major Buyers of Coagulation Factor XI
Table Distributors/Traders List
Figure United States Coagulation Factor XI Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Coagulation Factor XI Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Coagulation Factor XI Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Coagulation Factor XI Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Coagulation Factor XI Sales Volume Share Forecast by Region (2018-2025)
Figure United States Coagulation Factor XI Sales Volume Share Forecast by Region (2018-2025)
Figure United States Coagulation Factor XI Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications